<<

Central Journal of Neurology & Translational Neuroscience Bringing Excellence in Open Access

Review Article Corresponding author Professor Milan Jokanović, Department of Medicine, Ataxia in Patients Poisoned University of Nish, Nish, Serbia, Email: Submitted: 13 September 2017 with Organophosphorus Accepted: 05 October 2017 Published: 07 October 2017 ISSN: 2333-7087 Compounds Copyright Milan Jokanović* © 2017 Jokanović Department of Medicine, University of Nish, Nish, Serbia OPEN ACCESS

Abstract Keywords • Organophosphorus Approximately 90 years have passed since the first cases of • Organophosphate induced delayed polyneuropathy induced delayed polyneuropathy (OPIDP), as the consequence of human poisoning • Ataxia with certain organophosphorus compounds, were described in the literature. OPIDP is a relatively rare neurodegenerative disorder in humans characterized by loss of function, ataxia and paralysis of distal parts of sensory and motor axons in peripheral nerves and ascending and descending tracts of spinal cord appearing usually 2–3 weeks after exposure. The aim of this review is to discuss clinical presentation, pathogenesis and molecular mechanisms of OPIDP in man.

ABBREVIATIONS syndrome from the intermediate syndrome [3]. The interest in OPIDP was increased after thousands cases of poisoning with OPC: Organophosphorus Compounds; AChE: Acetylcho- triorthocresyl phosphate (TOCP) that occurred mainly due to linesterase; OPIDP Organophosphate-Induced Delayed Polyneu- : beverage and food contamination in USA in 1930 and Morocco ropathy; NTE: Neuropathy Target Esterase in 1959 [4-7]. By the end of twentieth century, there were many INTRODUCTION cases of OPIDP due to TOCP poisoning in Romania, Sri Lanka, former Yugoslavia and China. In addition to TOCP, several Organophosphorus compounds (OPC) have been used other OP pesticides have been reported to cause OPIDP in man as and developed as warfare nerve agents such (Table 1) [8-10]. Cases of OPIDP caused by pesticides were also as , , , VX and others. poisoning discussed by Lotti and Moretto [9] (Table 1). OPIDP is a rare results from occupational, accidental and intentional neurodegenerative disorder in humans characterized by loss of exposure. According to the World Health Organization, about function and ataxia of distal parts of sensory and motor axons in 1 million accidental and 2 million suicidal poisonings with peripheral nerves and ascending and descending tracts of spinal organophosphorus insecticides are reported per year, with more cord. The early neurological symptoms usually are sharp, cramp- than 300 000 fatalities and the average mortality more than 15% [1,2]. OPC cause several neurotoxic disorders in humans: a) the like pains in the calves, tingling in the feet and hands followed by syndrome or acute OP poisoning occurring after distal numbness and paresthesia. Pain and weakness in muscles (AChE) inhibition in the nervous system; b) spread rapidly and patients become unsteady and unable to keep the intermediate syndrome; c) chronic organophosphate-induced their balance. Progressive leg weakness occurs, together with neuropsychiatric disorder (COPIND); and d) organophosphate- induced delayed polyneuropathy (OPIDP). While the cholinergic arms and forearms. Sensory loss may be mild. Muscle tonus of depression of tendon reflexes. Symptoms may also appear in the syndrome is caused by all OPC (depending on dose) the OPIDP is the limbs gradually increase and spasticity appears in the lower not caused by warfare nerve agents [3]. The aim of this review limbs. Physical examination reveals distal symmetrical mainly is to discuss clinical presentation, pathogenesis and molecular mechanisms of OPIDP in man where ataxia and paralysis are distal limb muscles, especially in the lower limbs. In severe motor polyneuropathy, with wasting and flaccid weakness of the most important features. OPIDP is an interesting neurotoxic OPIDP quadriplegia with foot and wrist drop were observed as phenomenon caused by a single exposure to certain OPC with well as mild pyramidal signs [6]. There may be some functional clinical effects usually appearing after 10 to 20 days or later. recovery in less severe cases with more distal involvement and OPIDP is a different toxicological problem from cholinergic sparing of spinal cord axons, but pyramidal and other signs of syndrome since it is based on different mechanisms which do not central neurological involvement may become more evident involve AChE and appear a few weeks after acute OP poisoning with time [3]. The recovery affects only sensory nerves, while has been medically solved with standard therapeutic measures motor neurons may permanently lose its function as indicated and patient dismissed from hospital. OPIDP is also a different by Morgan [5] who described the lack of improvement during

Cite this article: Jokanović M (2017) Ataxia in Patients Poisoned with Organophosphorus Compounds. J Neurol Transl Neurosci 5(2): 1081. Jokanović (2017) Email:

Central Bringing Excellence in Open Access

Table 1: Organophosphorus pesticides reported to cause OPIDP in man (8-10). OP insecticide No of cases Location Year 2 Italy, India 1986 5 Romania, Turkey, Brasil, Korea, India 1980, 2002-2006 Ethyl 1 Germany 1993 3 USA 1985 Isofenphos 1 Israel 1987 Isofenphos/ 1 Italy 1995 80 USA 1974 2 Japan, Turkey 1991, 2009 Merphos 1 USA 1977 > 45 Sri Lanka, Italy, China, Turkey, USA 1981, 1998 1 Serbia 2010 3 UK 1952 1 France 1972 / 1 China 2002 Mevinphos Trichlorfon 22 Romania, Iran, Japan, Hungary 1983 -1986 Trichloronat 1 Poland 1975

47 years in 11 patients poisoned with TOCP. Tosi et al. [11], for NTE is considered to be lysolecithin [14]. NTE regulates also noted the absence of any improvement after 50 years in phospholipid and is known to be a phospholipase 7 patients exposed to TOCP. However, the study reported by B [15,16]. Inactivation of NTE may reduce the degradation of Wang et al. [12], conducted 13 years after TOCP poisoning of 74 patients revealed that out of 61 survivors, 35 patients almost of the NTE activity may lead to abnormal accumulation of regained normal function of limbs and work outside; 23 patients phosphatidylcholine-containingphosphatidylcholine to glycerophosphocholine. membranes in The cells, deficiency which walked with bilateral support and could perform housework; and may interfere with normal membrane lipid homeostasis and 3 patients could not self-care. Neurophysiological investigations showed normal electroencephalogram and visual, brainstem lysolecithin [14,17,18], the delay in initiation of neurites may also auditory and somatosensory evoked potentials. Motor evoked befluidity caused affecting by an theabnormal initiation accumulation of neurites. of Since lysolecithin NTE hydrolyzes in NTE- potential obtained from the upper limbs had normal central motor conduction time, but it was delayed or absent in bilateral lower limbs. Motor and sensory nerve conduction velocity and glialdeficient cells cells[20-22]. [19]. There NTE is a involved relationship in intracellular between NTE membrane activity electromyography studies were normal except for two severely andtrafficking the axonal and maintenance cell-signaling since pathway it facilitates between the transport neurons and affected patients. The prognosis for functional recovery depends of macromolecules from the neuron to the distal ends of long on the degree of pyramidal involvement with ataxia and axons [23]. It was also suggested that NTE may be involved in paralysis representing a permanent outcome of severe OPIDP. It the regulation of calcium entrance into cells being responsible appears that clinical signs of OPIDP in children are considerably for the maintenance of normal function of calcium channels, milder than in adults [4,9,12]. Electrophysiological evaluation and that increasing calcium activated neutral protease activity revealed partial denervation of affected muscles with abnormal is responsible for triggering OPIDP [24]. Medical treatment of OPIDP in humans is symptomatic. Standard treatment of OPC waves), increased insertional activity, reduced amplitude of poisoned patients comprising atropine, oxime and diazepam musclespontaneous action activitypotentials, (fibrillation delayed terminal potentials, motor positive latencies sharp and was not effective in treatment of OPIDP. However, there were motor conduction velocity slightly reduced or normal [4,6,13]. several reports in the literature describing attempts of treatment of OPIDP in animals and these studies were reviewed by Lotti [6] studies showing Wallerian-type degeneration of axons mainly affectingThese findings myelin are sheatsin accordance with aggregation, with the results accumulation of pathological and tested in patients so far. and Jokanović et al. [7], but none of these treatments have been several mechanisms of OPIDP have been proposed. OPIDP is ACKNOWLEDGEMENT initiatedpartial condensation by phosphorylation of neurofilaments and subsequent in the nervous aging of system >70% the enzyme originally known as neurotoxic esterase, but later from the Serbian Ministry of Science (Project 175045). renamed to neuropathy target esterase (NTE) in peripheral nerves The research of Professor Jokanović was supported by a grant [4,6]. NTE was discovered by Martin Johnson, who described REFERENCES its most important toxicological and biochemical features [4]. 1. Jeyaratnam J. Acute : a major global health NTE is an integral membrane protein in vertebrate neurons problem. World Health Stat Q. 1990; 43: 139-144. present in all neurons, but not in glia. The active site of NTE 2. Jokanovi M. Medical treatment of acute poisoning with 966 960 1086 contains Ser and two aspartates Asp and Asp that appear organophosphorus and pesticides. Toxicol Lett. 2009; 190: essential for enzymatic activity. The physiological substrate 107-115.ć

J Neurol Transl Neurosci 5(2): 1081 (2017) 2/3 Jokanović (2017) Email:

Central Bringing Excellence in Open Access

3. Jokanovi M, Kosanovi M, Brki D, Vukomanovi P. Organophosphate Natl Acad Sci U S A. 2003; 100: 7983-7987. induced delayed polyneuropathy in man: An overview. Clin Neurosurg 15. Read DJ, Li Y, Chao MV, Cavanagh JB, Glynn P. Neuropathy target Neurol. 2011;ć 1: 7-10. ć ć ć esterase is required for adult vertebrate axon maintenance. J Neurosci. 4. Johnson MK. The target for initiation of delayed neurotoxicity by 2009; 29: 11594-11600. organophosphorus esters: biochemical studies and toxicological 16. Chang PA, Wu YJ. Neuropathy target esterase: an essential enzyme for applications. Revews in Biochemical Toxicology. 1982; 4: 141-212. neural development and axonal maintenance. Int J Biochem Cell Biol. 5. Morgan JP. The Jamaica ginger paralysis. JAMA 1982; 248: 1864-1867. 2010; 42: 573-575. 6. Lotti M. The pathogenesis of organophosphate delayed 17. Vose SC, Fujioka K, Gulevich AG, Lin AY, Holland NT, Casida JE. Cellular polyneuropathy. Crit Rev Toxicol. 1992; 21: 465-487. function of neuropathy target esterase in lysophosphatidylcholine action. Toxicol Appl Pharmacol 2008; 232: 367-383. 7. delayed polyneuropathy. Med Chem Rev Online. 2004; 1: 123-131. 18. Greiner AJ, Richardson RJ, Worden RM, Ofoli RY. of Jokanović M, Kosanović M, Stukalov PV. Organophosphate induced lysophospholipid hydrolysis by the catalytic domain of neuropathy 8. target esterase on the Influence delayed polyneuropathy. Current Drug Targets - CNS & Neurological Jokanović M, Stukalov PV, Kosanović M. Organophosphate induced Biophys Acta. 2010; 1798: 1533-1539. Disorders. 2002; 1: 591-600. fluidity of bilayer lipid membranes. Biochim 19. Li Z, Szurek PF, Jiang C, Pao A, Bundy B, Le WD, et al. Neuronal 9. Lotti M, Moretto A. Organophosphate-induced delayed polyneuropathy. Toxicol Rev. 2005; 24: 37-49. Biophys Res Commun. 2005; 330: 1103-1109. 10. Jokanovic´ M, Kosanovic´ M. Neurotoxic effects in patients poisoned differentiation of NTE-deficient embryonic stem cells. Biochem 20. Atkins J, Glynn P. Membrane association of and critical residues in the with organophosphorus pesticides. Environ Toxicol Pharmacol. 2010; catalytic domain of human neuropathy target esterase. J Biol Chem. 29: 195-201. 2000; 275: 24477-24483. 11. Tosi L, Righetti C, Adami L, Zanette G. October 1942: a strange 21. van Tienhoven M, Atkins J, Li Z, Glynn P. Human neuropathy target epidemic paralysis in Saval, Verona, Italy. Revision and diagnosis esterase catalyzes hydrolysis of membrane lipids. J Biol Chem. 2002; 50 years later of tri-ortho-cresyl phosphate poisoning. J Neurol 277: 20942-20948. Neurosurg Psychiatry. 1994; 57: 810-813. 22. Glynn P. A mechanism for organophosphate-induced delayed 12. neuropathy. Toxicol Lett. 2006; 162: 94-97. Neuropathy: chemically-induced. In: Encyclopedia of Neuroscience, ChapterJokanović 515, M, Elsevier.Squire L, 2009;Albright 759-765. T, Bloom F, Gage F, Spitzer N editors. 23. Read DJ, Li Y, Chao MV, Cavanagh JB, Glynn P. Neuropathy target esterase is required for adult vertebrate axon maintenance. J Neurosci. 13. World Health Organization. Organophosphorus insecticides: a general 2009; 29: 11594-11600. introduction. Environmental Health Criteria, Geneva. 1986, 63. 24. Emerick GL, Peccinini RG, de Oliveira GH. Organophosphorus-induced 14. Quistad GB, Barlow C, Winrow CJ, Sparks SE, Casida JE. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc Toxicol Lett. 2010; 192: 238-244. delayed neuropathy: a simple and efficient therapeutic strategy.

Cite this article Jokanović M (2017) Ataxia in Patients Poisoned with Organophosphorus Compounds. J Neurol Transl Neurosci 5(2): 1081.

J Neurol Transl Neurosci 5(2): 1081 (2017) 3/3